港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

同源康医药-B

12.750

+0.0800.63%

成交量：90.40万

成交额：1,151.50万

市值：48.46亿

市盈率：-9.83

高：12.880

开：12.600

低：12.580

收：12.670

52周最高：46.100

52周最低：12.100

股本：3.80亿

香港流通股本：3.75亿

量比：0.54

换手率：0.24%

股息：- -

股息率：- -

每股收益(LYR):-1.298

净资产收益率：--

总资产收益率：-27.71%

市净率：11.99

市盈率(LYR):-9.83

市销率: 40003.87

数据加载中...

总览公司新闻资讯公告

同源康医药-B(02410)：联交所就实施H股全流通授出上市批准

每日卖空追踪 | 同源康医药-B 02月11日卖空量成交7000股，卖空比例为0.42%

同源康医药-B02月10日遭主力抛售93.1万元

同源康医药-B(02410)：甲磺酸艾多替尼片（TY-9591片）的新药上市申请获国家药品监督管理局受理

同源康医药－Ｂ(02410)股价上升5%，现价港币$13.23

阿斯达克财经

港股异动 | 同源康医药-B(02410)午后涨近5% 甲磺酸艾多替尼片获纳入优先审评品种名单

每日卖空追踪 | 同源康医药-B 02月04日卖空量成交500股，卖空比例为0.06%

浙江同源康医药（2410）1月无新增发行或股份变动

每日卖空追踪 | 同源康医药-B 02月02日卖空量成交9000股，卖空比例为0.36%

同源康医药-B02月02日遭主力抛售50.3万元

港股异动 | 同源康医药-B(02410)早盘涨超13% 甲磺酸艾多替尼片获纳入优先审评品种名单

同源康医药-B旗下阿散德替尼获国家药监局药品审评中心纳入优先审评品种名单

同源康医药-B(02410)在研1类新药甲磺酸艾多替尼片被国家药品监督管理局药品审评中心纳入优先审评品种名单

每日卖空追踪 | 同源康医药-B 01月29日卖空量成交7.9万股，卖空比例为3.21%

同源康医药-B01月29日遭主力抛售125.4万元

每日卖空追踪 | 同源康医药-B 01月28日卖空量成交9500股，卖空比例为0.17%

同源康医药－Ｂ(02410)出现大手卖出270万股，成交价$11.68，涉资3.154千万

阿斯达克财经

同源康医药(02410.HK)：一股东持460.8万股非上市股份转换H股完成中证监备案

阿斯达克财经

同源康医药(02410.HK)获浙江省药监局药品生产许可证

阿斯达克财经

同源康医药-B(02410)：中国证监会发出关于公司申请H股全流通的备案通知书

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02410/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02410","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"同源康医药-B","latestPrice":12.75,"timestamp":1770963982683,"preClose":12.67,"halted":0,"volume":904000,"delay":0,"changeRate":0.006314127861089193,"floatShares":375457818,"shares":380065818,"eps":-1.2975391738168744,"marketStatus":"交易中","change":0.08,"latestTime":"02-13 14:27:04","open":12.6,"high":12.88,"low":12.58,"amount":11514960,"amplitude":0.023678,"askPrice":12.75,"askSize":4500,"bidPrice":12.7,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-0.8738341987416468,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770970200000},"marketStatusCode":2,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":12.67,"openAndCloseTimeList":[[1770946200000,1770955200000],[1770958800000,1770969600000]],"volumeRatio":0.536145,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","floatShares":375457818,"roa":"-27.71%","roe":"--","lyrEps":-1.297539,"volumeRatio":0.536145,"shares":380065818,"dividePrice":0,"high":12.88,"amplitude":0.023678,"preClose":12.67,"low":12.58,"week52Low":12.1,"pbRate":"11.99","psRate":"40003.87","week52High":46.1,"institutionHeld":0,"latestPrice":12.75,"committee":-0.384615,"eps":-1.2975391738168744,"divideRate":0,"volume":904000,"delay":0,"ttmEps":-0.8738341987416468,"open":12.6,"prevYearClose":13.11,"prevWeekClose":12.9,"prevMonthClose":12.65,"prevQuarterClose":13.11,"fiveDayClose":12.9,"twentyDayClose":13.56,"sixtyDayClose":13.73},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02410\",params:#limit:5,,,undefined,":[{"date":"2025-08-31","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756603800000,"name":null,"time":"","dateTimestamp":1756569600000,"actualEps":null},{"date":"2025-03-27","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02410\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02410\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1747324800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02410\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02410","date":"2026-02-11","current":-14.48641,"percent":0.918033,"low":-45.171338,"twenty":-24.941363,"median":-18.905503,"eighty":-16.11716,"high":-10.104382,"avg":-20.837116,"sd":6.141127,"marketCap":4781227990},"quantilePoints":[{"date":"2024-08-23","current":-18.036629,"twenty":-16.647141,"median":-14.72623,"eighty":-12.008468,"marketCap":8010053668},{"date":"2024-08-30","current":-17.916348,"twenty":-18.108709,"median":-17.490261,"eighty":-14.277882,"marketCap":8010053668},{"date":"2024-09-06","current":-22.38992,"twenty":-20.387629,"median":-17.957821,"eighty":-15.985061,"marketCap":10531737231},{"date":"2024-09-13","current":-25.215246,"twenty":-24.52304,"median":-18.767123,"eighty":-16.911292,"marketCap":11829662594},{"date":"2024-09-20","current":-22.432724,"twenty":-24.518581,"median":-20.496807,"eighty":-17.208183,"marketCap":10587362603},{"date":"2024-09-27","current":-24.719835,"twenty":-24.497927,"median":-22.38992,"eighty":-17.671485,"marketCap":11736953639},{"date":"2024-10-04","current":-24.95032,"twenty":-24.87878,"median":-23.321155,"eighty":-17.932937,"marketCap":11792579012},{"date":"2024-10-10","current":-25.38933,"twenty":-24.941363,"median":-23.362473,"eighty":-17.973583,"marketCap":11922371548},{"date":"2024-10-18","current":-26.355956,"twenty":-25.311733,"median":-23.798709,"eighty":-18.108709,"marketCap":12311749157},{"date":"2024-10-25","current":-24.571342,"twenty":-25.374683,"median":-24.122054,"eighty":-18.545067,"marketCap":11477368567},{"date":"2024-11-01","current":-18.445843,"twenty":-25.311733,"median":-23.998666,"eighty":-18.584118,"marketCap":8621932768},{"date":"2024-11-08","current":-20.323115,"twenty":-25.278482,"median":-23.623818,"eighty":-17.973583,"marketCap":9456313359},{"date":"2024-11-15","current":-19.45318,"twenty":-25.171449,"median":-23.425489,"eighty":-18.108709,"marketCap":8955685004},{"date":"2024-11-22","current":-24.620137,"twenty":-24.988066,"median":-23.362473,"eighty":-18.406793,"marketCap":11329034239},{"date":"2024-11-29","current":-31.047836,"twenty":-25.311733,"median":-23.554037,"eighty":-18.584118,"marketCap":14277178993},{"date":"2024-12-06","current":-34.758675,"twenty":-25.786797,"median":-23.737743,"eighty":-19.168188,"marketCap":15945940174},{"date":"2024-12-13","current":-35.961329,"twenty":-26.0415,"median":-24.070769,"eighty":-19.324298,"marketCap":16465110319},{"date":"2024-12-20","current":-44.500897,"twenty":-30.298107,"median":-24.44033,"eighty":-19.494791,"marketCap":20284719244},{"date":"2024-12-27","current":-43.273475,"twenty":-31.455257,"median":-24.553474,"eighty":-19.619623,"marketCap":19709923726},{"date":"2025-01-03","current":-39.042242,"twenty":-33.760908,"median":-24.669986,"eighty":-19.709581,"marketCap":17800119264},{"date":"2025-01-10","current":-16.73771,"twenty":-34.083555,"median":-24.719835,"eighty":-19.709581,"marketCap":7602134269},{"date":"2025-01-17","current":-16.071561,"twenty":-33.760908,"median":-24.553474,"eighty":-18.860667,"marketCap":7305465614},{"date":"2025-01-24","current":-20.268382,"twenty":-32.413923,"median":-24.349989,"eighty":-19.230133,"marketCap":9270895450},{"date":"2025-01-28","current":-18.549699,"twenty":-31.591026,"median":-24.122054,"eighty":-18.549699,"marketCap":8529223814},{"date":"2025-02-07","current":-17.965815,"twenty":-31.472067,"median":-23.871541,"eighty":-18.275892,"marketCap":8214013368},{"date":"2025-02-14","current":-19.878813,"twenty":-31.451054,"median":-23.623818,"eighty":-18.275892,"marketCap":9066935750},{"date":"2025-02-21","current":-25.066745,"twenty":-31.047836,"median":-23.789321,"eighty":-18.32609,"marketCap":11495910358},{"date":"2025-02-28","current":-26.244856,"twenty":-30.411824,"median":-23.765234,"eighty":-18.39703,"marketCap":11996538712},{"date":"2025-03-07","current":-24.725844,"twenty":-30.135297,"median":-23.927628,"eighty":-18.445843,"marketCap":11347576030},{"date":"2025-03-14","current":-23.101371,"twenty":-29.84324,"median":-23.977848,"eighty":-18.549699,"marketCap":10605904394},{"date":"2025-03-21","current":-22.868028,"twenty":-28.789228,"median":-23.789321,"eighty":-18.691799,"marketCap":10494653649},{"date":"2025-03-28","current":-28.703724,"twenty":-28.703724,"median":-23.977848,"eighty":-19.110968,"marketCap":13146129748},{"date":"2025-04-03","current":-29.204856,"twenty":-29.744706,"median":-24.122054,"eighty":-19.131966,"marketCap":12070705875},{"date":"2025-04-11","current":-24.387234,"twenty":-29.307899,"median":-24.067881,"eighty":-19.145106,"marketCap":10012567086},{"date":"2025-04-17","current":-24.599189,"twenty":-28.955479,"median":-24.067881,"eighty":-19.224594,"marketCap":10123817831},{"date":"2025-04-25","current":-24.758022,"twenty":-28.755026,"median":-24.236021,"eighty":-19.282593,"marketCap":10197984995},{"date":"2025-05-02","current":-30.859428,"twenty":-28.772127,"median":-24.368612,"eighty":-19.308976,"marketCap":12738210348},{"date":"2025-05-09","current":-26.222368,"twenty":-28.789228,"median":-24.487968,"eighty":-19.376573,"marketCap":11477368567},{"date":"2025-05-16","current":-19.875071,"twenty":-28.703724,"median":-24.44033,"eighty":-19.45318,"marketCap":8770267095},{"date":"2025-05-23","current":-18.391406,"twenty":-28.460584,"median":-24.320388,"eighty":-19.147078,"marketCap":8139846205},{"date":"2025-05-30","current":-16.767615,"twenty":-28.328721,"median":-24.116277,"eighty":-18.777931,"marketCap":7453799941},{"date":"2025-06-06","current":-19.720458,"twenty":-27.077703,"median":-23.93026,"eighty":-18.847277,"marketCap":8788808886},{"date":"2025-06-13","current":-16.18601,"twenty":-26.697665,"median":-23.850097,"eighty":-18.709822,"marketCap":7216465018},{"date":"2025-06-20","current":-14.05098,"twenty":-26.664525,"median":-23.778892,"eighty":-18.426653,"marketCap":6252291891},{"date":"2025-06-27","current":-16.3221,"twenty":-26.630078,"median":-23.66211,"eighty":-18.32609,"marketCap":7283215465},{"date":"2025-07-04","current":-17.493079,"twenty":-26.41078,"median":-23.623818,"eighty":-18.194509,"marketCap":7806093968},{"date":"2025-07-11","current":-16.487526,"twenty":-26.267076,"median":-23.430941,"eighty":-17.964216,"marketCap":7349965912},{"date":"2025-07-18","current":-15.867745,"twenty":-26.226866,"median":-23.321155,"eighty":-17.866761,"marketCap":7068130691},{"date":"2025-07-25","current":-16.407488,"twenty":-26.143659,"median":-23.070409,"eighty":-17.335488,"marketCap":7335132480},{"date":"2025-08-01","current":-14.539711,"twenty":-26.072617,"median":-22.868028,"eighty":-17.325642,"marketCap":6459959949},{"date":"2025-08-08","current":-15.316665,"twenty":-25.987382,"median":-22.563641,"eighty":-17.04089,"marketCap":6822181433},{"date":"2025-08-15","current":-17.450454,"twenty":-25.968574,"median":-22.406203,"eighty":-16.915178,"marketCap":7760944003},{"date":"2025-08-22","current":-13.484776,"twenty":-25.95357,"median":-22.354126,"eighty":-16.718364,"marketCap":5978435317},{"date":"2025-08-29","current":-12.516323,"twenty":-25.925655,"median":-21.46252,"eighty":-16.486483,"marketCap":5575565550},{"date":"2025-09-05","current":-19.23268,"twenty":-25.919389,"median":-21.226743,"eighty":-16.486483,"marketCap":5883418862},{"date":"2025-09-12","current":-18.156363,"twenty":-25.850806,"median":-20.678772,"eighty":-16.541494,"marketCap":5564163575},{"date":"2025-09-19","current":-18.839434,"twenty":-25.807696,"median":-20.500943,"eighty":-16.56352,"marketCap":5769399117},{"date":"2025-09-26","current":-19.348832,"twenty":-25.743581,"median":-20.268382,"eighty":-16.654406,"marketCap":5910023469},{"date":"2025-10-03","current":-22.468168,"twenty":-25.650075,"median":-20.314843,"eighty":-16.707921,"marketCap":6879191305},{"date":"2025-10-10","current":-19.927643,"twenty":-25.596841,"median":-20.323115,"eighty":-16.732368,"marketCap":6092455062},{"date":"2025-10-17","current":-19.134493,"twenty":-25.519561,"median":-20.155539,"eighty":-16.749672,"marketCap":5845412280},{"date":"2025-10-24","current":-17.635142,"twenty":-25.404318,"median":-19.980008,"eighty":-16.781291,"marketCap":5389333299},{"date":"2025-10-31","current":-19.024541,"twenty":-25.400784,"median":-19.927643,"eighty":-16.830147,"marketCap":5822608331},{"date":"2025-11-07","current":-17.694439,"twenty":-25.37593,"median":-19.869193,"eighty":-16.945559,"marketCap":5412137248},{"date":"2025-11-14","current":-17.099248,"twenty":-25.321084,"median":-19.741813,"eighty":-16.951188,"marketCap":5244908288},{"date":"2025-11-21","current":-15.19815,"twenty":-25.311733,"median":-19.694587,"eighty":-16.919035,"marketCap":4659606928},{"date":"2025-11-28","current":-16.711808,"twenty":-25.293455,"median":-19.641679,"eighty":-16.730587,"marketCap":5142290517},{"date":"2025-12-05","current":-17.262657,"twenty":-25.275139,"median":-19.635782,"eighty":-16.587841,"marketCap":5320921452},{"date":"2025-12-12","current":-16.160016,"twenty":-25.213434,"median":-19.544821,"eighty":-16.497144,"marketCap":4990264190},{"date":"2025-12-19","current":-16.355316,"twenty":-25.19336,"median":-19.414876,"eighty":-16.454475,"marketCap":5062476695},{"date":"2025-12-24","current":-15.692499,"twenty":-25.154877,"median":-19.348832,"eighty":-16.406101,"marketCap":4872443786},{"date":"2026-01-02","current":-15.765099,"twenty":-25.10227,"median":-19.292077,"eighty":-16.35327,"marketCap":4914251026},{"date":"2026-01-09","current":-17.392186,"twenty":-25.070347,"median":-19.235279,"eighty":-16.345574,"marketCap":5434941197},{"date":"2026-01-16","current":-16.438751,"twenty":-25.06473,"median":-19.137216,"eighty":-16.35327,"marketCap":5153692492},{"date":"2026-01-23","current":-15.75073,"twenty":-25.023112,"median":-19.120814,"eighty":-16.314941,"marketCap":4933254317},{"date":"2026-01-30","current":-15.280433,"twenty":-24.971672,"median":-19.022068,"eighty":-16.22453,"marketCap":4807832597},{"date":"2026-02-06","current":-15.542994,"twenty":-24.952303,"median":-18.937078,"eighty":-16.152588,"marketCap":4902849052},{"date":"2026-02-11","current":-15.09436,"twenty":-24.941363,"median":-18.905503,"eighty":-16.11716,"marketCap":4781227990}],"updateTime":1770936129117},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02410\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610945167","title":"同源康医药-B(02410)：联交所就实施H股全流通授出上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2610945167","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610945167?lang=zh_cn&edition=fundamental","pubTime":"2026-02-12 17:07","pubTimestamp":1770887224,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B(02410)公布，公司已向联交所上市委员会申请批准公司根据转换公司1名股东持有的460.8万股非上市股份转换的460.8万股H股上市及买卖经转换H股。联交所已于2026年2月11日授出上市批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404690.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","02410","09939","BK1515","159938"],"gpt_icon":0},{"id":"2610961373","title":"每日卖空追踪 | 同源康医药-B 02月11日卖空量成交7000股，卖空比例为0.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610961373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610961373?lang=zh_cn&edition=fundamental","pubTime":"2026-02-11 16:30","pubTimestamp":1770798633,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月11日，跌1.41%，卖空量成交7000股，较上一交易日减少81.08%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163427a6ee1e74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211163427a6ee1e74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02410","BK1161","BK1515","09939"],"gpt_icon":0},{"id":"2610605754","title":"同源康医药-B02月10日遭主力抛售93.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610605754","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610605754?lang=zh_cn&edition=fundamental","pubTime":"2026-02-10 16:16","pubTimestamp":1770711368,"startTime":"0","endTime":"0","summary":"02月10日, 同源康医药-B股价跌0.78%，报收12.76元，成交金额2489.9万元，换手率0.51%，振幅3.89%，量比0.87。同源康医药-B今日主力资金净流出93.1万元，上一交易日主力净流出134.1万元。该股近5个交易日上涨3.24%，主力资金累计净流出3.5万元；近20日主力资金累计净流出211.7万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210162335a492ad01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210162335a492ad01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","02410","BK1515","09939"],"gpt_icon":0},{"id":"2609856571","title":"同源康医药-B(02410)：甲磺酸艾多替尼片（TY-9591片）的新药上市申请获国家药品监督管理局受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2609856571","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609856571?lang=zh_cn&edition=fundamental","pubTime":"2026-02-06 17:02","pubTimestamp":1770368535,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B 发布公告，本公司在研1类新药甲磺酸艾多替尼片的新药上市申请被国家药品监督管理局药品审评中心受理。甲磺酸艾多替尼片作为奥希替尼的氘代化合物，无论是从化学结构、药理作用、临床有效性和安全性、以及耐药机制分析，甲磺酸艾多替尼片都显示出更明显的临床价值和优势，对疾病的预后有明显改善作用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402563.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02410","BK1161","09939","BK1515","159938","TY"],"gpt_icon":0},{"id":"2609355446","title":"同源康医药－Ｂ(02410)股价上升5%，现价港币$13.23","url":"https://stock-news.laohu8.com/highlight/detail?id=2609355446","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609355446?lang=zh_cn&edition=fundamental","pubTime":"2026-02-06 14:34","pubTimestamp":1770359640,"startTime":"0","endTime":"0","summary":"[上升股]同源康医药－Ｂ(02410) 股价在下午02:34比前收市价上升5%，现股价为港币$13.23。至目前为止，今日最高价为$13.23，而最低价为$12.33。总成交量为277.35万股，总成交金额为港币$3.561千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2602062089/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2602062089/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["159938","BK1574","BK1515","BK1161","02410","09939"],"gpt_icon":0},{"id":"2609786559","title":"港股异动 | 同源康医药-B(02410)午后涨近5% 甲磺酸艾多替尼片获纳入优先审评品种名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2609786559","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609786559?lang=zh_cn&edition=fundamental","pubTime":"2026-02-06 14:19","pubTimestamp":1770358758,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B(02410)午后涨近5%，截至发稿，涨3.65%，报13.06港元，成交额2890.62万港元。消息面上，同源康医药此前公布，公司在研1类新药甲磺酸艾多替尼片(TY-9591片)被国家药品监督管理局(NMPA)药品审评中心(CDE)纳入优先审评品种名单。据悉，该药物拟用于治疗具有表皮生长因子受体(EGFR)外显子19缺失或外显子21置换突变，并伴有中枢神经系统转移的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者的一线治疗。此次被纳入优先评审，标志着甲磺酸艾多替尼片的审评进程将全面提速，有望更早上市，为中国患者提供新的治疗选择。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402459.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","BK1515","VT","BK1161","BK4588","BK4585","VXUS","BK1574","02410","159938"],"gpt_icon":0},{"id":"2608986043","title":"每日卖空追踪 | 同源康医药-B 02月04日卖空量成交500股，卖空比例为0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608986043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608986043?lang=zh_cn&edition=fundamental","pubTime":"2026-02-04 16:30","pubTimestamp":1770193830,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月04日，涨0.08%，卖空量成交500股，较上一交易日减少80%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163637a6d20465&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163637a6d20465&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09939","BK1515","02410"],"gpt_icon":0},{"id":"1110153215","title":"浙江同源康医药（2410）1月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1110153215","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110153215?lang=zh_cn&edition=fundamental","pubTime":"2026-02-03 17:36","pubTimestamp":1770111387,"startTime":"0","endTime":"0","summary":"浙江同源康医药股份有限公司（02410）于2026年2月3日披露截至2026年1月31日的股份变动月报表。公告显示，公司当月未有新增发行、购回或注销等股份变动事宜，股本结构维持稳定。\n公司注册股本总计为人民币380,065,818元，其中H股股份数为375,457,818股，非上市股份数为4,608,000股。本月报表显示，上述H股与非上市股份数量均无增减，分别保持在375,457,818股和4,608,000股。\n根据公告，公司确认当前符合香港联交所主板上市规则所要求的公众持股量规定，且并无股份期权、股权激励计划或可转换债券等相关变动。月报由执行董事、董事长兼总裁吴豫生签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410"],"gpt_icon":0},{"id":"2608850786","title":"每日卖空追踪 | 同源康医药-B 02月02日卖空量成交9000股，卖空比例为0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608850786","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608850786?lang=zh_cn&edition=fundamental","pubTime":"2026-02-02 16:30","pubTimestamp":1770021030,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间02月02日，跌3%，卖空量成交9000股，较上一交易日减少50%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163651a6c985c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202163651a6c985c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1515","02410","09939"],"gpt_icon":0},{"id":"2608713850","title":"同源康医药-B02月02日遭主力抛售50.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608713850","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608713850?lang=zh_cn&edition=fundamental","pubTime":"2026-02-02 16:15","pubTimestamp":1770020129,"startTime":"0","endTime":"0","summary":"02月02日, 同源康医药-B股价跌3.00%，报收12.27元，成交金额3124.7万元，换手率0.67%，振幅6.09%，量比0.58。同源康医药-B今日主力资金净流出50.3万元，连续5日净流出，上一交易日主力净流出65.1万元。该股近5个交易日下跌3.39%，主力资金累计净流出742.7万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入427.8万元，其中净流入天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202161753a6c97173&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260202161753a6c97173&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1515","02410","09939"],"gpt_icon":0},{"id":"2607306694","title":"港股异动 | 同源康医药-B(02410)早盘涨超13% 甲磺酸艾多替尼片获纳入优先审评品种名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2607306694","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607306694?lang=zh_cn&edition=fundamental","pubTime":"2026-01-30 09:35","pubTimestamp":1769736942,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B(02410)早盘涨超13%，截至发稿，涨8.94%，报13.52港元，成交额4070.33万港元。消息面上，同源康医药公布，公司在研1类新药甲磺酸艾多替尼片(TY-9591片)被国家药品监督管理局(NMPA)药品审评中心(CDE)纳入优先审评品种名单。据悉，该药物拟用于治疗具有表皮生长因子受体(EGFR)外显子19缺失或外显子21置换突变，并伴有中枢神经系统转移的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者的一线治疗。此次被纳入优先评审，标志着甲磺酸艾多替尼片的审评进程将全面提速，有望更早上市，为中国患者提供新的治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399541.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK4585","BK1515","02410","BK4588","159938","BK1161","VT","09939"],"gpt_icon":0},{"id":"1193030035","title":"同源康医药-B旗下阿散德替尼获国家药监局药品审评中心纳入优先审评品种名单","url":"https://stock-news.laohu8.com/highlight/detail?id=1193030035","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193030035?lang=zh_cn&edition=fundamental","pubTime":"2026-01-29 17:16","pubTimestamp":1769678166,"startTime":"0","endTime":"0","summary":"同源康医药股份有限公司宣布，其研发的阿散德替尼（Asandeutertinib）已被中国国家药品监督管理局药品审评中心正式纳入优先审评品种名单。这一重要进展标志着该药物在临床价值和市场潜力方面获得了监管机构的高度认可。\n优先审评资格的获得，将有望显著缩短阿散德替尼的审评审批时间，加速其在中国市场的上市进程，从而惠及更多患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02410","BK1161"],"gpt_icon":0},{"id":"2607702571","title":"同源康医药-B(02410)在研1类新药甲磺酸艾多替尼片被国家药品监督管理局药品审评中心纳入优先审评品种名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2607702571","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607702571?lang=zh_cn&edition=fundamental","pubTime":"2026-01-29 17:08","pubTimestamp":1769677696,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B(02410)公布，公司在研1类新药甲磺酸艾多替尼片(TY-9591片)被国家药品监督管理局(NMPA)药品审评中心(CDE)纳入优先审评品种名单。甲磺酸艾多替尼片(TY-9591片)拟定的适应症为具有EGFR外显子19缺失(19DEL) 或外显子21(L858R)置换突变，并伴有CNS转移的局部晚期或转移性NSCLC成人患者的一线治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399178.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02410","BK1515","159938","BK1161","09939"],"gpt_icon":0},{"id":"2607037664","title":"每日卖空追踪 | 同源康医药-B 01月29日卖空量成交7.9万股，卖空比例为3.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607037664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607037664?lang=zh_cn&edition=fundamental","pubTime":"2026-01-29 16:30","pubTimestamp":1769675432,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间01月29日，跌0.32%，卖空量成交7.9万股，较上一交易日增加558.33%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164013a6bae324&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164013a6bae324&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","02410","BK1515","BK1161","BK1574"],"gpt_icon":0},{"id":"2607037669","title":"同源康医药-B01月29日遭主力抛售125.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607037669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607037669?lang=zh_cn&edition=fundamental","pubTime":"2026-01-29 16:15","pubTimestamp":1769674516,"startTime":"0","endTime":"0","summary":"01月29日, 同源康医药-B股价跌0.32%，报收12.41元，成交金额3030.7万元，换手率0.65%，振幅3.37%，量比0.89。同源康医药-B今日主力资金净流出125.4万元，连续3日净流出，上一交易日主力净流出296.9万元。该股近5个交易日下跌4.91%，主力资金累计净流出544.2万元；近20日主力资金累计净流入804.5万元，其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129161629a6bac912&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129161629a6bac912&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1574","02410","BK1161","BK1515"],"gpt_icon":0},{"id":"2607348777","title":"每日卖空追踪 | 同源康医药-B 01月28日卖空量成交9500股，卖空比例为0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607348777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607348777?lang=zh_cn&edition=fundamental","pubTime":"2026-01-28 16:30","pubTimestamp":1769589030,"startTime":"0","endTime":"0","summary":"同源康医药-B北京时间01月28日，跌0.32%，卖空量成交9500股，较上一交易日增加72.73%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128164835a45f8ca1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128164835a45f8ca1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","09939","02410","BK1574"],"gpt_icon":0},{"id":"2606375734","title":"同源康医药－Ｂ(02410)出现大手卖出270万股，成交价$11.68，涉资3.154千万","url":"https://stock-news.laohu8.com/highlight/detail?id=2606375734","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606375734?lang=zh_cn&edition=fundamental","pubTime":"2026-01-28 09:00","pubTimestamp":1769562000,"startTime":"0","endTime":"0","summary":"[大手成交]同源康医药－Ｂ(02410)在上午09:00出现大手卖出，成交量为270万，成交价为港币$11.68，涉资3.154千万。至目前为止，股价跌3.523%，今日最高价为$11.68，而最低价为$11.68，总成交量为270万股，总成交金额港币$3.154千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150431576_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2601281/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2601281/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09939","BK1574","BK1161","159938","02410","BK1515"],"gpt_icon":0},{"id":"2606937267","title":"同源康医药(02410.HK)：一股东持460.8万股非上市股份转换H股  完成中证监备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2606937267","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606937267?lang=zh_cn&edition=fundamental","pubTime":"2026-01-26 10:01","pubTimestamp":1769392860,"startTime":"0","endTime":"0","summary":"同源康医药－Ｂ(02410.HK) 公布，近日，中国证监会已就H股全流通向公司发出备案通知书。1名股东持有460.8万股非上市股份转换为相同数目H股的H股全流通的中国证监会备案已告完成。于完成有关转 换及联交所授予上市批准后，该等460.8万股H股将于联交所主板上市及买卖。 备案通知书将自中国证监会核准之日起12个月内有效。H股全流通的实施计划详情尚未最终确定。(hc/w)(港股报价延迟最少十五分钟。沽空资料截至 2026-01-23 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240819111846106_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240819111846106_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1498559/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1498559/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09939","BK1161","159938","02410","BK1515","BK1574"],"gpt_icon":0},{"id":"2606107254","title":"同源康医药(02410.HK)获浙江省药监局药品生产许可证","url":"https://stock-news.laohu8.com/highlight/detail?id=2606107254","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606107254?lang=zh_cn&edition=fundamental","pubTime":"2026-01-25 18:09","pubTimestamp":1769335740,"startTime":"0","endTime":"0","summary":"同源康医药－Ｂ(02410.HK) 公布，获浙江省药品监督管理局颁发药品生产许可证，生产范围甲磺酸艾多替尼片。预期将对公司扩大产能及拓展市场产生长远的积极作用，为后续开展商业化生产奠定基础。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2026-01-23 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20250911164657656_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20250911164657656_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1498468/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1498468/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","02410","BK1515","159938","BK1161","09939"],"gpt_icon":0},{"id":"2605474003","title":"同源康医药-B(02410)：中国证监会发出关于公司申请H股全流通的备案通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2605474003","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605474003?lang=zh_cn&edition=fundamental","pubTime":"2026-01-23 19:48","pubTimestamp":1769168893,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B(02410)发布公告，近日中国证监会已就H股全流通向公司发出备案通知书。根据备案通知书，有关公司1名股东持有460.8万股非上市股份转换为460.8万股H股的H股全流通的中国证监会备案已告完成。于完成有关转换及联交所授予上市批准后，该等460.8万股H股将于联交所主板上市及买卖。备案通知书将自中国证监会核准之日起12个月内有效。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1396845.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","02410","BK1161","09939","BK1515","159938"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":132,"code":"91000000","status":"200"}]}}